Similar articles

• The pill, HRT and postoperative thromboembolism: cause for concern?

  Whitehead EM, Whitehead MI. Whitehead EM, et al. Anaesthesia. 1991 Jul;46(7):521-2. doi: 10.1111/j.1365-2044.1991.tb09646.x. Anaesthesia. 1991. PMID: 1862887 No abstract available.
• Letter: Thromboembolism, oral contraceptives, and oestrogen concentration gradient.

  Mueller H, Stadel BV. Mueller H, et al. Lancet. 1975 Mar 22;1(7908):683-4. doi: 10.1016/s0140-6736(75)91785-7. Lancet. 1975. PMID: 47105 No abstract available.
• Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content.

  Böttiger LE, Boman G, Eklund G, Westerholm B. Böttiger LE, et al. Lancet. 1980 May 24;1(8178):1097-101. doi: 10.1016/s0140-6736(80)91550-0. Lancet. 1980. PMID: 6103437
• [Estrogens and cardiovascular diseases: should current guidelines be changed?].

  Beller F, Theiss W. Beller F, et al. Zentralbl Gynakol. 1994;116(8):441-8. Zentralbl Gynakol. 1994. PMID: 7941812 Review. German.
• Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease.

  Mammen EF. Mammen EF. Hematol Oncol Clin North Am. 2000 Oct;14(5):1045-59, vii-viii. doi: 10.1016/s0889-8588(05)70170-2. Hematol Oncol Clin North Am. 2000. PMID: 11005033 Review.